Magnetic resonance imaging and spectroscopy in cancer theranostic imaging

Research output: Contribution to journalReview articlepeer-review

Abstract

With its exquisite anatomical resolution and wide-ranging functional imaging capabilities, magnetic resonance imaging (MRI) has found multiple applications in detection, staging, and monitoring treatment response in cancer. The metabolic information provided by magnetic resonance spectroscopy (MRS) is being actively investigated to complement MRI parameters, as well as existing biomarkers, in cancer detection and in monitoring response to treatment. Located at the interface of detection and therapy, theranostic imaging is a rapidly expanding new field that is showing significant promise for precision medicine of cancer. Innovations in the development of novel nanoparticles decorated with imaging reporters that can be used to deliver therapeutic cargo to specific cells and environments have provided new roles for MRI and MRS in theranostic imaging.

Original languageEnglish (US)
Pages (from-to)215-221
Number of pages7
JournalTopics in Magnetic Resonance Imaging
Volume25
Issue number5
DOIs
StatePublished - Nov 1 2016

Keywords

  • Cancer
  • MRI
  • MRS
  • Theranostic imaging
  • Tumor microenvironment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Magnetic resonance imaging and spectroscopy in cancer theranostic imaging'. Together they form a unique fingerprint.

Cite this